Abstract
We have identified and characterized a new gene sequence, TXNRD3NT1, whose transcripts, corresponding to the EST AA430236, were found by Affymetrix DNA chip analysis to be significantly down regulated in affected psoriatic tissue. The full-length cDNA of TXNRD3NT1 was isolated and characterized by combining 5′- and 3′-RACE (rapid amplication of cDNA ends) with screening a keratinocyte cDNA library, designing appropriate PCR primers, cloning amplified products, sequencing, and sequence analysis. Because part of this gene overlaps the previously described thioredoxin reductase 3 (TXNRD3) gene, we have named it TXNRD3NT1 (TXNRD3 new transcript 1). The full-length TXNRD3NT1 cDNA has 1133 nucleotides with a 251-bp 3-UTRand 2 poly(A)signal variants and 2 poly (A) sites. The TXNRD3NT1 cDNA ORF encodes for 133 amino acids, with the first four residues coding for a tubulin-β mRNA autoregulation signal. Mapping the cDNA nucleotide sequence to the human genome sequence revealed that the TXNRD3NT1 gene has 4 exons located on Chromosome 3, at position 3q21. Exons 1 and 2 of the TXNRD3NT1 gene overlap with exons 15 and 16 of the thioredoxin reductase 2 gene which has different ORFs to that of TXNRD3NT1. The translation initiation codon ATG was found in exon 3 of the TXNRD3NT1 gene. RT-PCR showed that the full-length variant of the TXNRD3NT1 gene was expressed in only four issues (pancreas, esophagus, bone marrow, and keratinocytes) of the 30 different tissues tested. In most other tissues, an aberrant and truncated form of the transcript (i.e., missing exon 3 and part of exon 4) was detected. The result of a preliminary association study between psoriasis and single microsatellite marker of the TXNRD3NT1 gene suggests that it may not be a significant genetic determinant of psoriasis. However, we cannot exclude the possibility that other sequence variants may still exist within the TXNRD3NT1 gene. Sequence analysis of the TXNRD3NT1 gene from 8 psoriasis patients and 8 healthy controls revealed a number of synonymous SNPs that may be useful markers for future disease association studies.
Similar content being viewed by others
References
SF Altschul W Gish W Miller EW Myers DJ Lipman (1990) ArticleTitleBasic local alignment search tool J Mol Biol. 215 403–410 Occurrence Handle10.1006/jmbi.1990.9999
AJ Bannister A Cook T Kouzarides (1991) ArticleTitleIn vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes Oncogene 6 IssueID7 1243–1250
C Biguet N Wakasugi Z Mishal A Holmgren S Chouaib et al. (1994) ArticleTitleThioredoxin increases the proliferation of human B-cell lines through a protein kinase C-dependent mechanism J Biol Chem. 269 IssueID46 28865–28870
MF Champliaud A Viel HP Baden (2003) ArticleTitleThe expression of vitamin D-upregulated protein 1 in skin and its interaction with sciellin in cultured keratinocytes J Invest Dermatol. 121 IssueID4 781–785 Occurrence Handle10.1046/j.1523-1747.2003.12539.x
JA Cromlish RG Roeder (1989) ArticleTitleHuman transcription factor IIIC (TFIIIC) Purification, polypeptide structure, and the involvement of thiol groups in specific DNA binding J Biol Chem. 264 IssueID30 18100–18109
C Didier I Kerblat C Drouet A Favier J-C Beani et al. (2001) ArticleTitleInduction of thioredoxin by ultraviolet-A radiation prevents oxidative-mediated cell death in human fibroblasts Free Rad Biol Med. 31 585–598 Occurrence Handle10.1016/S0891-5849(01)00617-7
F Enlund L Samuelsson C Enerback A Inerot J Wahlstrom et al. (1999) ArticleTitlePsoriasis susceptibility locus in chromosome region 3q21 identified in patients from southwest Sweden Eur J Hum Genet. 7 783–790 Occurrence Handle10.1038/sj.ejhg.5200365
ML Ericson J Horling V Wendel–Hansen A Holmgren A Rosen (1992) ArticleTitleSecretion of thioredoxin after in vitro activation of human B cells Lymphokine Cytokine Res. 11 IssueID5 201–207
PY Gasdaska JR Gasdaska S Cochran G Powis (1995) ArticleTitleCloning and sequencing of a human thioredoxin reductase FEES Lett. 373 IssueID1 5–9 Occurrence Handle10.1016/0014-5793(95)01003-W
S Hayashi K Hajiro–Nakanishi Y Makino H Eguchi J Yodoi et al. (1997) ArticleTitleFunctional modulation of estrogen receptor by redox state with reference to thioredoxin as a mediator Nucleic Acids Res. 25 IssueID20 4035–4040 Occurrence Handle10.1093/nar/25.20.4035
T Henseler (1998) ArticleTitleGenetics of psoriasis Arch Dermatol Res. 290 4463–4476 Occurrence Handle10.1007/s004030050338
D Hewett L Samuelsson J Polding F Enlund D Smart et al. (2002) ArticleTitleIdentification of a psoriasis susceptibility candidate gene by linkage disequilibrium mapping with a localized single nucleotide polymorphism map Genomics 79 IssueID3 305–314 Occurrence Handle10.1006/geno.2002.6720
K Hirota M Matsui S Iwata A Nishiyama K Mori et al. (1997) ArticleTitleAP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1 Proc Natl Acad Sci USA 94 IssueID8 3633–3638 Occurrence Handle10.1073/pnas.94.8.3633
K Hirota H Nakamura H Masutani J Yodoi (2002) ArticleTitleThioredoxin superfamily and thioredoxin-inducing agents Ann NY Acad Sci. 957 189–199
A Holmgren (1985) ArticleTitleThioredoxin Annu Rev Biochem. 54 237–271 Occurrence Handle10.1146/annurev.bi.54.070185.001321
E Junn SH Han JY Im Y Yang EW Cho et al. (2000) ArticleTitleVitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function J Immunol. 164 6287–6295
TC Laurent EC Moore P Reichard (1964) ArticleTitleEnzymatic synthesis of deoxyribonucleotides IV. Isolation and characterization of thioredoxin, the hydrogen donor from Escherichia coli B. J Biol Chem. 239 3436–3444
Y Matsuzaka S Makino K Nakajima M Tomizawa A Oka et al. (2000) ArticleTitleNew polymorphic microsatellite markers in the human MHC class II region Tissue Antigens 56 492–500 Occurrence Handle10.1034/j.1399-0039.2000.560602.x Occurrence Handle1:CAS:528:DC%2BD3MXktV2itA%3D%3D Occurrence Handle11169238
Y Matsuzaka K Okamoto H Tsuji T Mabuchi A Ozawa et al. (2002) ArticleTitleIdentification of the hRDH-E2 gene, a novel member of the SDR family, and its increased expression in psoriatic lesion Biochem Biophys Res Commun. 297 1171–1180 Occurrence Handle10.1016/S0006-291X(02)02344-6
JR Matthews N Wakasugi JL Virelizier J Yodoi RT Hay (1992) ArticleTitleThioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62 Nucleic Acids Res. 20 IssueID15 3821–3830
H Nakamura K Nakamura J Yodoi (1997) ArticleTitleRedox regulation of cellular activation Annu Rev Immunol. 15 351–369 Occurrence Handle10.1146/annurev.immunol.15.1.351
GW Newman MK Balcewicz–Sablinska JR Guarnaccia HG Remold DS Silberstein (1994) ArticleTitleOpposing regulatory effects of thioredoxin and eosinophil cytotoxicity-enhancing factor on the development of human immunodeficiency virus 1 J Exp Med. 180 IssueID1 359–363 Occurrence Handle10.1084/jem.180.1.359
A Nishiyama M Matsui S Iwata K Hirota H Masutani et al. (1999) ArticleTitleIdentification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression J Biol Chem. 274 21645–21650 Occurrence Handle10.1074/jbc.274.31.21645
JH Oh AS Chung H Steinbrenner H Sies P Brenneisen (2004) ArticleTitleThioredoxin secreted upon ultraviolet A irradiation modulates activities of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in human dermal fibroblasts Arch Biochem Biophys. 423 IssueID1 218–226 Occurrence Handle10.1016/j.abb.2003.12.026
A Oka G Tamiya M Tomizawa M Ota Y Katsuyama et al. (1999) ArticleTitleAssociation analysis using refined microsatellite markers localizes a susceptibility locus for psoriasis vulgaris within a 111kb segment telomeric to the HLA-C gene Hum Mol Genet. 8 2165–2170 Occurrence Handle10.1093/hmg/8.12.2165
P Reichard (1993) ArticleTitleFrom RNA to DNA, why so many ribonucleotide reductases? Science 260 1773–1777
A Rubartelli A Bajetto G Allavena E Wollman Sitia (1992) ArticleTitleSecretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway J Biol Chem. 267 IssueID34 24161–24164
M Saitoh H Nishitoh M Fujii K Takeda K Tobiume et al. (1998) ArticleTitleMammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1 EMBO J. 17 IssueID9 2596–2606 Occurrence Handle10.1093/emboj/17.9.2596
KU Schallreuter JM Wood (2001) ArticleTitleThioredoxin reductaser—its role in epidermal redox status J Photochem Photobiol B. 64 179–184 Occurrence Handle10.1016/S1011-1344(01)00235-4
Q-A Sun Y Wu F Zappacosta K-T Jeang BJ Lee et al. (1999) ArticleTitleRedox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases J Biol Chem. 247 24522–24530 Occurrence Handle10.1074/jbc.274.35.24522
T Tamura TC Stadtman (1996) ArticleTitleA new selenoprotein from human lung adenocarcinoma cells: purification, properties, and thioredoxin reductase activity Proc Natl Acad Sci USA 93 IssueID3 1006–1011 Occurrence Handle10.1073/pnas.93.3.1006
H Tanaka Y Makino K Okamoto T Iida K Yan et al. (1999) ArticleTitleRedox regulation of the glucocorticoid receptor Antioxid Redox Signal 1 IssueID4 403–423
MB Toledano WJ Leonard (1991) ArticleTitleModulation of transcription factor NF-kappa B binding activity by oxidation–reduction in vitro Proc Natl Acad Sci USA 88 IssueID10 4328–4332
H Tsuji K Okamoto Y Matsuzaka H lizuka G Tamiya et al. (2003) ArticleTitleSLURP-2, a novel member of the human Ly-6 superfamily that is up-regulated in psoriasis vulgaris Genomics 81 26–33 Occurrence Handle10.1016/S0888-7543(02)00025-3
N Wakasugi Y Tagaya H Wakasugi A Mitsui M Maeda et al. (1990) ArticleTitleAdult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein–Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2 Proc Natl Acad Sci USA 87 IssueID21 8282–8286
TJ Yen PS Machlin DW Cleveland (1988) ArticleTitleAutoregulated instability of beta-tubulin mRNAs by recognition of the nascent amino terminus of beta-tubulin Nature 334 580–585 Occurrence Handle10.1038/334580a0
Author information
Authors and Affiliations
Corresponding author
Additional information
GenBank accession number for human TXNRD3NT1 cDNA is AB113648.
Rights and permissions
About this article
Cite this article
Matsuzaka, Y., Okamoto, K., Mabuchi, T. et al. Identification and characterization of novel variants of the thioredoxin reductase 3 new transcript 1 TXNRD3NT1. Mamm Genome 16, 41–49 (2005). https://doi.org/10.1007/s00335-004-2416-y
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00335-004-2416-y